Roddenberry Center for Stem Cell Biology and Medicine
In 2011, Gladstone founded the Roddenberry Center for Stem Cell Biology and Medicine with an unprecedented $5 milion gift from the Roddenberry Foundation to honor Star Trek creator Gene Roddenberry. Deepak Srivastava, MD, leads the Center, which, in part, builds on pioneering work by Nobel laureate and Gladstone Senior Investigator Shinya Yamanaka, MD, PhD. Dr. Yamanaka’s 2006 discovery of induced pluripotent stem cells, or iPS cells, revolutionized the fields of cell biology and stem cell research—opening promising new avenues for both personalized and regenerative medicine. The Center, which collaborates with the Center for iPS Cell Research and Application, is creating models of human disease based on iPS cells to speed drug development for a number of devastating cardiovascular, viral, and neurological conditions.
Scientists working at the Center apply the pioneering principles of stem cell biology to advance studies of human health. Through the Center, scientists gain resources to follow up on promising but uncertain scientific leads and move a promising biomedical discovery through all the rigorous tests required for clinical applications.